Table 4 Cost-effectiveness analysis results over the CRICERVA study for all ages
Group | Cost | Incremental coverage (%) | ICER(1) | ICER(2) |
|---|---|---|---|---|
No intervention (NIG) | 86.13€ | |||
IG1 (letter) | 86.62€ | 17.6% | 2.78 | 2.78 (IG1 vs NIG) |
IG2 (letter + leaflet) | 87.97€ | 16.7% | 11.02 | Dominated (IG2 vs IG1) |
IG3 (letter + leaflet + phone call) | 89.11€ | 21.7% | 13.73 | 60.73 (IG3 vs IG1) |